60 DEGREES PHARMACEUTICALS

Company snapshot

60 Degrees Pharmaceuticals, INC develops and commercializes new medicines to treat and prevent infectious diseases with a product focus on ARAKODA for malaria prevention, and a research focus on tickborne disease.

• 5 active pipeline program(s) linked via ClinicalTrials.gov.
• 5 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for 60 DEGREES PHARMACEUTICALS. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for 60 DEGREES PHARMACEUTICALS.

1. Jun 8, 2026 Clinical update

   Tafenoquine Oral Tablet — Phase 2

2. Jun 5, 2026 Clinical update

   Tafenoquine 100mg — Phase 2

3. May 23, 2026 Clinical update

   Celgosivir — Phase 2

4. May 23, 2026 Clinical update

   Tafenoquine — Phase 2

5. May 23, 2026 Clinical update

   Tafenoquine — Phase 2

View all clinical trial activity →

• What is 60 DEGREES PHARMACEUTICALS?

  60 Degrees Pharmaceuticals is a pharma organization headquartered in Washington, USA. It trades on NYSE under ticker SXTP. Primary therapeutic focus areas include Dengue Fever, Chronic Babesiosis, Babesiosis, COVID 19 Disease. NovaPharmaNews links 5 clinical program(s), 0 drug pr

• Is 60 DEGREES PHARMACEUTICALS publicly traded?

  Yes. 60 DEGREES PHARMACEUTICALS is listed with ticker SXTP on NYSE per SEC EDGAR records linked on this profile.

• What drugs does 60 DEGREES PHARMACEUTICALS develop or market?

  We link 2 drug profile(s) where 60 DEGREES PHARMACEUTICALS is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/60-degrees-pharmaceuticals-inc#company-drugs.

• What are the latest developments for 60 DEGREES PHARMACEUTICALS?

  In the last 12 months our linked public records show 5 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does 60 DEGREES PHARMACEUTICALS focus on?

  60 DEGREES PHARMACEUTICALS focuses on Dengue Fever, Chronic Babesiosis, Babesiosis based on our analysis of their pipeline programs and drug development activities.